Financial Statements — GBIO
Balance Sheet
(in millions USD)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 21.94 | 49.09 | 50.89 | 21.66 | 28.50 | 35.53 | 93.36 | 144.97 | 95.65 | 134.49 | 158.26 | 336.98 | 388.35 | 392.07 | 366.30 |
| Short-term Investments | 67.68 | 92.27 | 106.67 | 163.11 | 188.44 | 183.78 | 197.67 | 169.17 | 193.00 | 166.68 | 153.94 | -- | 10.02 | 33.12 | 84.78 |
| Accounts Receivable | 0.39 | 0.26 | 1.39 | 2.21 | 1.34 | 0.00 | 0.66 | 0.34 | 1.81 | 0.40 | 1.78 | -- | -- | -- | -- |
| Total Current Assets | 93.46 | 145.50 | 165.12 | 191.25 | 223.28 | 226.85 | 297.81 | 320.62 | 344.73 | 310.56 | 321.13 | 341.56 | 403.27 | 432.74 | 455.79 |
| Property, Plant & Equipment | 8.85 | 13.30 | 14.43 | 16.01 | 17.09 | 18.59 | 22.38 | 21.97 | 22.03 | 23.44 | 24.89 | 27.85 | 22.96 | 23.61 | 23.20 |
| Total Non-current Assets* | 28.43 | 33.93 | 36.23 | 57.53 | 41.98 | 59.03 | 83.68 | 84.26 | 86.68 | 92.24 | 97.86 | 102.46 | 60.76 | 58.05 | 58.30 |
| Total Assets | 121.90 | 179.43 | 201.35 | 248.78 | 265.26 | 285.88 | 381.49 | 404.88 | 431.42 | 402.80 | 418.99 | 444.03 | 464.03 | 490.79 | 514.08 |
| Accounts Payable | 2.06 | 2.23 | 2.26 | 1.66 | 1.91 | 1.48 | 2.65 | 2.33 | 1.50 | 1.69 | 1.09 | 1.55 | 0.52 | 0.59 | 0.30 |
| Total Current Liabilities | 21.04 | 19.37 | 19.60 | 30.17 | 30.10 | 28.31 | 32.82 | 26.48 | 22.74 | 17.32 | 16.18 | 15.25 | 14.51 | 13.93 | 10.79 |
| Total Non-current Liabilities* | 50.30 | 105.96 | 108.42 | 114.18 | 119.75 | 125.58 | 116.76 | 124.12 | 129.54 | 76.73 | 77.94 | 75.86 | 42.32 | 43.46 | 44.55 |
| Total Liabilities | 71.34 | 125.33 | 128.02 | 144.34 | 149.86 | 153.89 | 149.58 | 150.60 | 152.28 | 94.05 | 94.12 | 91.11 | 56.82 | 57.39 | 55.35 |
| Retained Earnings | (744.29) | (738.77) | (717.85) | (681.66) | (666.35) | (645.92) | (536.19) | (507.92) | (476.86) | (412.36) | (381.05) | (343.12) | (277.18) | (245.33) | (214.54) |
| Total Stockholder Equity | 50.56 | 54.10 | 73.33 | 104.44 | 115.41 | 131.99 | 231.91 | 254.29 | 279.14 | 308.75 | 324.87 | 352.92 | 407.21 | 433.40 | 458.74 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Total Revenue | 1.59 | 0.77 | 8.72 | 4.19 | 7.55 | 4.09 | 4.06 | 2.88 | 2.15 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Research & Development | 21.63 | 15.50 | 15.36 | 15.49 | 15.09 | 16.39 | 14.34 | 27.92 | 21.86 | 21.83 | 22.00 | 21.61 | 21.19 | 28.37 | 25.55 | 21.85 | 21.99 | 22.66 | 18.75 |
| Selling, General & Admin | 12.16 | 7.67 | 8.83 | 8.66 | 9.18 | 9.52 | 10.43 | 13.38 | 11.64 | 12.97 | 12.87 | 13.08 | 11.48 | 10.12 | 9.79 | 9.10 | 9.67 | 8.19 | 6.90 |
| Total Operating Expenses | 8.30 | 23.68 | 25.33 | 27.75 | 25.44 | 27.40 | 81.69 | 41.30 | 33.50 | 34.80 | 34.87 | 34.69 | 32.67 | 38.48 | 35.34 | 30.95 | 31.66 | 30.84 | 25.66 |
| Operating Income | (6.71) | (22.92) | (16.61) | (23.56) | (17.88) | (23.31) | (77.63) | (38.42) | (31.36) | (33.92) | (34.87) | (34.69) | (32.67) | (38.48) | (35.34) | (30.95) | (31.66) | (30.84) | (25.65) |
| Net Income | (5.52) | (20.92) | (14.80) | (21.38) | (15.31) | (20.43) | (74.54) | (35.19) | (28.27) | (31.07) | (32.09) | (32.40) | (31.31) | (37.93) | (35.00) | (30.94) | (31.85) | (30.79) | (25.56) |
| Basic EPS | (0.82) | (3.12) | (0.22) | (0.32) | (0.23) | (0.31) | (1.12) | (0.53) | (0.43) | (0.47) | (0.53) | (0.55) | (0.53) | (0.66) | (0.61) | -- | -- | -- | -- |
| Diluted EPS | (0.82) | (3.12) | (0.22) | (0.32) | (0.23) | (0.31) | (1.12) | (0.53) | (0.43) | (0.47) | (0.53) | (0.55) | (0.53) | (0.66) | (0.61) | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Operating Cash Flow | (52.68) | (16.83) | (28.36) | (15.78) | (19.55) | (21.53) | (31.70) | (24.98) | (24.90) | 24.81 | (27.68) | (23.00) | (20.48) | (23.53) | (35.43) | (20.80) | (22.55) | (25.44) | (23.03) |
| Capital Expenditures | 0.00 | 0.46 | 0.25 | 0.38 | 0.09 | 0.01 | 1.92 | 4.58 | 0.61 | 1.45 | 0.76 | 0.68 | 0.65 | 4.68 | 2.78 | 2.84 | 0.94 | 1.27 | 0.92 |
| Free Cash Flow* | (52.68) | (17.29) | (28.61) | (16.16) | (19.64) | (21.55) | (33.61) | (29.56) | (25.51) | 23.35 | (28.43) | (23.68) | (21.13) | (28.22) | (38.22) | (23.64) | (23.49) | (26.70) | (23.94) |
| Investing Cash Flow | 25.53 | 14.95 | 2.96 | 70.28 | 12.71 | 12.09 | (0.55) | (1.91) | (26.58) | 24.42 | (5.62) | (18.40) | (12.61) | (158.72) | (2.78) | 7.17 | 22.17 | 50.23 | 113.49 |
| Financing Cash Flow | -0.00 | 0.08 | (0.01) | 0.14 | -0.00 | 0.23 | (0.12) | 0.08 | (0.13) | 0.10 | 35.77 | 0.08 | 9.31 | 3.54 | 0.05 | 0.44 | 0.31 | 0.97 | 212.96 |
* Derived from reported values
